[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100414125":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":30,"locations":38,"responsibleParty":54,"collaborators":56,"id":67,"slug":12,"hasResults":68,"nctId":69,"briefTitle":70,"officialTitle":70,"acronym":71,"eligibilityCriteria":72,"healthyVolunteers":68,"sex":73,"minAge":74,"maxAge":75,"enrollmentInfo":76,"targetDuration":12,"studyType":79,"phases":80,"briefSummary":82,"conditions":83,"keywords":87,"overallStatus":41,"whyStopped":12,"lastUpdateSubmitDate":92,"lastUpdatePostDateStruct":93,"startDateStruct":96,"completionDateStruct":98,"leadSponsor":100,"locationsCount":101},{"fullName":5,"class":6},"University of Zurich","OTHER",[8,13],{"label":9,"type":10,"description":11,"interventionNames":12},"Waitlist control group","NO_INTERVENTION","The intervention group consists of 30 patients diagnosed with PTSD induced by ACS. No intervention or any other procedure will be conducted during the study period of 36 weeks. Afterwards these subjects will be offered an EMDR therapy as provided in the intervention.",null,{"label":14,"type":15,"description":16,"interventionNames":17},"Intervention group","EXPERIMENTAL","The intervention group consists of 30 patients diagnosed with PTSD induced by ACS. Eight individual EMDR sessions lasting for 1 hours will be provided over 8 weeks by licensed EMDR therapists from the German-speaking part of Switzerland. Each EMDR session follows a standardized 8-phase protocol.",[18],"Behavioral: EMDR Treatment",[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":12},"BEHAVIORAL","EMDR Treatment","Eight individual EMDR sessions lasting for 1 hours will be provided over 8 weeks by licensed EMDR therapists from the German-speaking part of Switzerland. Each EMDR session follows a standardized 8-phase protocol.",[14],[26],{"name":27,"affiliation":28,"role":29},"Christoph Mueller-Pfeiffer, PD Dr. med.","University of Zurich\u002FUniversity Hospital Zurich","PRINCIPAL_INVESTIGATOR",[31,35],{"name":27,"role":32,"phone":33,"phoneExt":12,"email":34},"CONTACT","+41 44 255 52 80","christoph.mueller-pfeiffer@access.uzh.ch",{"name":36,"role":32,"phone":33,"phoneExt":12,"email":37},"Mary Princip, PD Dr. phil.","mary.princip@usz.ch",[39],{"facility":40,"status":41,"city":42,"state":12,"zip":12,"country":43,"countryCode":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":51},"University Hospital Zurich","RECRUITING","Zurich","Switzerland","CH",{"type":46,"coordinates":47},"Point",[48,49],8.55,47.36667,{"lat":49,"lon":48},[52],{"name":53,"role":32,"phone":12,"phoneExt":12,"email":12},"Mary Princip",{"type":55,"investigatorFullName":12,"investigatorTitle":12,"investigatorAffiliation":12,"oldNameTitle":12,"oldOrganization":12},"SPONSOR",[57,60,63,65],{"name":58,"class":59},"EMDR Europe","INDUSTRY",{"name":61,"class":62},"Stiftung zur Förderung von Psychiatrie und Psychotherapie","UNKNOWN",{"name":64,"class":62},"EMDR Foundation",{"name":66,"class":62},"EMDO Stiftung","100414125",false,"NCT04672551","EMDR Treatment in PTSD Following Cardiac Events","EMDR_PTSD_MI","Inclusion Criteria:\n\n* Age between 18-70 years\n* Men or women\n* STEMI (irrespective of troponin, but ST-elevation) or non-STEMI (troponin positive) at the time of the cardiac event, as verified by the cardiologist\n* Diagnosis of PTSD caused by the cardiac event\n\nExclusion Criteria:\n\n* Psychotic disorder, bipolar disorder, substance abuse as measured with the Mini International Neuropsychiatric Interview (M.I.N.I)\n* Acute suicidal ideation as assessed with the M.I.N.I.\n* Non-selective beta blockers (e.g., propranolol) during the study period\n* Ongoing psychological\u002Fpsychiatric treatment outside of the trial during the study period\n* Visionary problems, e.g. strabismus, which does not allow adequate eye movements\n* Insufficient knowledge of the German language\n* Expected inability or willingness to follow the study protocol\n* Regular medication with benzodiazepine","ALL","18 Years","70 Years",{"count":77,"type":78},60,"ESTIMATED","INTERVENTIONAL",[81],"NA","Cardiac events can often result in debilitating and persistent psychological symptoms. A key question involves whether optimal treatment of cardiac-induced posttraumatic stress disorder (PTSD) reduces PTSD symptoms and thereby may offset the risk of recurrent or worsening cardiovascular disease. Cardiac-induced PTSD 1) is prevalent, 2) features symptoms unique to internal ongoing somatic threat, with fears and worries that can be distinguished from PTSD resulting from external causes, 3) is persistent, 4) is associated with negative physical and emotional consequences, and 5) has not been the subject of randomized-controlled treatment trials (RCT). There is preliminary evidence suggesting that patients with cardiac-disease induced PTSD might particularly profit from EMDR. Nevertheless, this possibility has not been tested in cardiac-induced PTSD. Currently, patients with cardiac-induced PTSD are not routinely offered trauma-focused therapies, with a lack of scientific evidence likely being one major reason for this omission. If our proposed RCT shows that EMDR can be an effective treatment for patients with ACS-induced PTSD, EMDR could be routinely implemented as first-line treatment. The RCT outcomes might inform larger trials to test whether poor prognosis in terms of major adverse cardiovascular events can be improved through EMDR in patients with cardiac-induced PTSD.",[84,85,86],"Posttraumatic Stress Disorder","Myocardial Infarction","Eye Movement Desensitization and Reprocessing",[88,89,90,91],"PTSD","MI","ACS","EMDR","2026-05-06",{"date":94,"type":95},"2026-05-07","ACTUAL",{"date":97,"type":95},"2020-11-21",{"date":99,"type":78},"2027-11-30",{"name":5,"class":6},1]